AP-325
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AP-325, covering 2024-10-16 to 2025-01-10. Get the full timeline:
Most recent: Clinical Trial Update: Effects of GABAA Receptor Modulation by AP-325 on Insulin Secretion in Patients with Type 2 Diabetes [Phase 2]